Dr. Gareth Morgan of the UAMS Myeloma Institute joins us to share more about the Myeloma Genome Project, a global effort to create a broad collection of high-quality genomic and clinical data from multiple myeloma patients to improve diagnosis, prognosis and treatment. The project will compile a broad set of genetic data and resulting outcomes to develop a strategy to segment patients into groups for more specific types of treatment. It also hopes to develop specific tests for disease-associated genetic mutations. The project is already integrating data sets from the UAMS Myeloma Institute, the National Cancer Research Institute's Myeloma XI trial, Intergroupe Francophone du Myeloma/Dana-Farber Cancer, and the Multiple Myeloma Research Foundation. Hear more about what has been learned so far and the future of this important project. Thanks to our episode sponsor, Takeda Oncology.